Key Takeaways
- Margin expansion despite flat revenue: Consolidated EBITDA margin rose 210 bps YoY even as domestic sales merely matched last year, driven by value engineering, softer inputs, and product mix.
- Australia turnaround is a zero-sum game for now: IMPCO Mexico delivered its best-ever H1, but Australia losses fully offset that gain at the consolidated level. The restructuring is on track, with the real payoff pushed to next year.
- Alternate channels are now structural: The alternate channel contributes >30% of annual sales, up from ~10% pre-COVID, a shift that changes the company's go-to-market profile permanently.
- Management is shutting down short-term guidance: A new IR policy means no revenue or EBITDA guidance, and competitive sensitivity blocked price-increase quantification. Investors must now judge the business on reported performance alone.
- What to watch next quarter: Whether channel inventory normalizes by season-end as planned, the pace of Australia's cost-base reduction, and any early signal on the summer season's strength in core GCC export markets.
Margin Drivers & Cost Structure
- Gross margin up 330 bps: Steady price increases, a decent sales mix, new model launches, moderating input costs, and more efficient logistics all contributed. Management declined to quantify the price component, citing competitive reasons.
- Three levers, ~5% EBITDA lift: The combination of gross margin improvement, favourable freight and forwarding costs, and lower other overheads and expenses together drove the consolidated margin expansion.
- Standalone margin leap: Standalone EBITDA margin moved from 21.6% to 26.8%, reflecting the same gross margin and cost-efficiency dynamics playing out in the domestic business.
- Australia CODB collapsing: The cost base is on track to end FY23-24 below AUD 0.7 crore, down from ~AUD 1.5 crore pre-acquisition, a reduction of over 50%. Next year it falls further.
Shah: "what we have earned from IMPCO Mexico, that we lost in Australia. So, ultimately, both put together has become a zero-sum game."
Australia Restructuring
- The transformation is structural, not tactical: The business is shifting from installed products to mobile products, which carry better value propositions, stronger demand, and higher margins. Manufacturing has moved from in-house to an outsourced model, and distribution now leverages the retail channel.
- Cost reduction largely achieved: Most manufacturing facilities have been outsourced, and the heavy lifting on the cost base is done. The transition will be largely complete by the end of this financial year.
- The payoff is a FY25 story: Management expects the full benefit and effect of the transition to show up next year (2024-2025), once the cost base stabilizes at the new, lower level and the product-mix shift gains traction.
- Mexico is the bright spot: IMPCO Mexico delivered its highest-ever H1 and Q2 revenue, demonstrating that the international portfolio has pockets of genuine strength even as Australia weighs on the consolidated result.
Domestic Demand & Channel Dynamics
- Flat billing, but not a demand problem: Q2 billing was very close to the same quarter last year, achieved through network expansion and deeper rural market penetration. The erratic summer season suppressed offtake, not underlying placement.
- Channel inventory slightly elevated: Net inventory at the end of Q2 was a touch higher than the same point last year. Management is working on plans to normalize it within the coming season, though the outcome is subject to weather.
- Alternate channel now >30% of sales: The channel mix has structurally shifted from ~10% pre-COVID to over 30% annually, a change that reduces dependence on any single route to market.
- Adjacent categories gaining traction: The company has successfully entered adjacent product categories and diversified into distribution channels suited to those products, broadening the addressable market beyond core air coolers.
Product & Market Expansion
- New domestic launches: The quarter saw new ranges in the desert cooler category (Windblast and Jumbo Plus Air Series) and an entry into the kitchen segment with Duet i, signalling a push beyond seasonal cooling.
- Global launch of Buddy: A smaller table-top cooler launched this quarter, targeting international markets with a compact form factor.
- Market share intact: Symphony maintains approximately 50% market share in the organized air cooler industry, with management asserting continued market and thought leadership.
- GSK China self-sustaining: The China subsidiary has delivered steady performance and has not required assistance from Symphony India for the last 1.5 years, suggesting the operation has reached a stable, independent footing.
International Markets & Geopolitical Exposure
- Long-term structural drivers intact: Despite temporary challenges, management sees intensified heat waves and climate change as durable tailwinds for overseas markets.
- Core GCC markets stable: It is premature to comment on the season's impact, but core GCC markets are not currently affected, and management does not anticipate major concern.
- Egypt and Sri Lanka recovering slowly: Traction is building but conditions have not yet normalized. Management sees positive movement and hopes for continued improvement.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Australia CODB reduction | End FY23-24 below AUD 0.7 crore (vs ~AUD 1.5 crore pre-acquisition); further reduction next year | FY23-24 exit / FY24-25 |
| Australia transition completion | Transition largely complete; full benefit and effect visible | End of current financial year / next year (2024-2025) |
| Channel inventory normalization | Bring to normal levels, subject to weather | By end of coming season |
| No short-term or medium-term guidance | New IR policy: focus on actual performance and delivery | Effective immediately |
Shah: "in line with most of the consumer durable and consumer facing companies, we are not going to issue any guidance, whether short term or medium term. Let us more focus on actual performance and delivery."
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Revenue (consolidated) | ₹275 cr, marginally higher YoY |
| Revenue (standalone) | ₹196 cr, in line with Q2 last year; domestic sales ₹191 cr |
| EBITDA (standalone) | ₹53 cr, up 13% YoY |
| EBITDA margin (standalone) | 26.8%, up in excess of 5 ppt YoY from 21.6% |
| PAT (standalone) | ₹50 cr, up 11% YoY |
| PAT margin (standalone) | 25.4%, up 470 bps YoY, including treasury income |
| EBITDA (consolidated) | ₹42 cr, up 16% YoY |
| EBITDA margin (consolidated) | 15.5%, up 210 bps YoY |
| PAT (consolidated) | ₹35 cr, up 10% YoY |
| PAT margin (consolidated) | 12.7% |
| ROCE (standalone core business) | 296% |
| ROCE (consolidated core business) | 37% |
| Return on net worth (standalone) | 21% |
| Treasury (standalone) | ₹589 cr, excluding equity investment and loans to subsidiaries |
| Capital employed (standalone, TTM monthly avg) | ₹55 cr, marginally lower YoY |
| Market share (organized sector) | ~50% |
| Alternate channel sales share | >30% of annual sales, vs ~10% pre-COVID |
| Climate Technologies Australia H1 revenue | ₹91 cr, vs ₹115 cr in H1 last year |
| Climate Technologies Australia H1 EBITDA | negative ₹14 cr, vs negative ₹11 cr in H1 last year |
| IMPCO Mexico H1 revenue | ₹107 cr, vs ₹69 cr in H1 last year |
| IMPCO Mexico H1 EBITDA | positive ₹18 cr, vs ₹7 cr in H1 last year |
| GSK China H1 revenue | ₹23 cr, vs ₹19 cr in H1 last year |
| GSK China H1 EBITDA | positive ₹3 cr, vs ₹1 cr in H1 last year |
| Second interim dividend | ₹2 per share, amounting to ₹14 cr |
| CODB reduction Australia (FY23-24) | less than AUD 0.7 cr, down from ~AUD 1.5 cr pre-acquisition |